182 related articles for article (PubMed ID: 24438191)
1. Metastasis of prostate cancer and melanoma cells in a preclinical in vivo mouse model is enhanced by L-plastin expression and phosphorylation.
Riplinger SM; Wabnitz GH; Kirchgessner H; Jahraus B; Lasitschka F; Schulte B; van der Pluijm G; van der Horst G; Hämmerling GJ; Nakchbandi I; Samstag Y
Mol Cancer; 2014 Jan; 13():10. PubMed ID: 24438191
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of ectopically expressed L-plastin enhances invasiveness of human melanoma cells.
Klemke M; Rafael MT; Wabnitz GH; Weschenfelder T; Konstandin MH; Garbi N; Autschbach F; Hartschuh W; Samstag Y
Int J Cancer; 2007 Jun; 120(12):2590-9. PubMed ID: 17290393
[TBL] [Abstract][Full Text] [Related]
3. Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over.
Al Tanoury Z; Schaffner-Reckinger E; Halavatyi A; Hoffmann C; Moes M; Hadzic E; Catillon M; Yatskou M; Friederich E
PLoS One; 2010 Feb; 5(2):e9210. PubMed ID: 20169155
[TBL] [Abstract][Full Text] [Related]
4. L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness.
Machado RAC; Stojevski D; De Landtsheer S; Lucarelli P; Baron A; Sauter T; Schaffner-Reckinger E
Cell Commun Signal; 2021 Feb; 19(1):22. PubMed ID: 33618712
[TBL] [Abstract][Full Text] [Related]
5. Suppression of prostate carcinoma cell invasion by expression of antisense L-plastin gene.
Zheng J; Rudra-Ganguly N; Powell WC; Roy-Burman P
Am J Pathol; 1999 Jul; 155(1):115-22. PubMed ID: 10393844
[TBL] [Abstract][Full Text] [Related]
6. The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner.
Janji B; Vallar L; Al Tanoury Z; Bernardin F; Vetter G; Schaffner-Reckinger E; Berchem G; Friederich E; Chouaib S
J Cell Mol Med; 2010 Jun; 14(6A):1264-75. PubMed ID: 19799649
[TBL] [Abstract][Full Text] [Related]
7. L-plastin regulates polarization and migration in chemokine-stimulated human T lymphocytes.
Freeley M; O'Dowd F; Paul T; Kashanin D; Davies A; Kelleher D; Long A
J Immunol; 2012 Jun; 188(12):6357-70. PubMed ID: 22581862
[TBL] [Abstract][Full Text] [Related]
8. L-plastin Ser5 phosphorylation in breast cancer cells and in vitro is mediated by RSK downstream of the ERK/MAPK pathway.
Lommel MJ; Trairatphisan P; Gäbler K; Laurini C; Muller A; Kaoma T; Vallar L; Sauter T; Schaffner-Reckinger E
FASEB J; 2016 Mar; 30(3):1218-33. PubMed ID: 26631483
[TBL] [Abstract][Full Text] [Related]
9. L-plastin phosphorylation: a novel target for the immunosuppressive drug dexamethasone in primary human T cells.
Wabnitz GH; Michalke F; Stober C; Kirchgessner H; Jahraus B; van den Boomen DJ; Samstag Y
Eur J Immunol; 2011 Nov; 41(11):3157-69. PubMed ID: 21805466
[TBL] [Abstract][Full Text] [Related]
10. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
11. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of L-plastin in colorectal carcinoma.
Li J; Zhao R
J Gastrointest Surg; 2011 Nov; 15(11):1982-8. PubMed ID: 21922341
[TBL] [Abstract][Full Text] [Related]
13. Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
Labelle-Côté M; Dusseault J; Ismaïl S; Picard-Cloutier A; Siegel PM; Larose L
BMC Cancer; 2011 Oct; 11():443. PubMed ID: 21992144
[TBL] [Abstract][Full Text] [Related]
14. AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin.
Chen C; Cai Q; He W; Lam TB; Lin J; Zhao Y; Chen X; Gu P; Huang H; Xue M; Liu H; Su F; Huang J; Zheng J; Lin T
Cell Death Dis; 2017 Oct; 8(10):e3060. PubMed ID: 28981098
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly in cells.
Janji B; Giganti A; De Corte V; Catillon M; Bruyneel E; Lentz D; Plastino J; Gettemans J; Friederich E
J Cell Sci; 2006 May; 119(Pt 9):1947-60. PubMed ID: 16636079
[TBL] [Abstract][Full Text] [Related]
16. The actin-bundling protein L-plastin-A double-edged sword: Beneficial for the immune response, maleficent in cancer.
Schaffner-Reckinger E; Machado RAC
Int Rev Cell Mol Biol; 2020; 355():109-154. PubMed ID: 32859369
[TBL] [Abstract][Full Text] [Related]
17. L-plastin nanobodies perturb matrix degradation, podosome formation, stability and lifetime in THP-1 macrophages.
De Clercq S; Boucherie C; Vandekerckhove J; Gettemans J; Guillabert A
PLoS One; 2013; 8(11):e78108. PubMed ID: 24236012
[TBL] [Abstract][Full Text] [Related]
18. Discovery and characterization of two novel human cancer-related proteins using two-dimensional gel electrophoresis.
Leavitt J
Electrophoresis; 1994; 15(3-4):345-57. PubMed ID: 8055865
[TBL] [Abstract][Full Text] [Related]
19. Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.
Xu M; Wang X; Pan Y; Zhao X; Yan B; Ruan C; Xia L; Zhao Y
BMC Cancer; 2019 Jun; 19(1):599. PubMed ID: 31208371
[TBL] [Abstract][Full Text] [Related]
20. Steroid hormone induction and expression patterns of L-plastin in normal and carcinomatous prostate tissues.
Zheng J; Rudra-Ganguly N; Miller GJ; Moffatt KA; Cote RJ; Roy-Burman P
Am J Pathol; 1997 Jun; 150(6):2009-18. PubMed ID: 9176394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
